Abstract
The question facing African governments and societies, say Rosen and colleagues, is not whether to ration such therapy, but how to do so in a way that maximizes social welfare.
Publication types
-
Research Support, U.S. Gov't, Non-P.H.S.
MeSH terms
-
Acquired Immunodeficiency Syndrome / drug therapy*
-
Acquired Immunodeficiency Syndrome / economics*
-
Africa
-
Anti-Retroviral Agents / economics*
-
Anti-Retroviral Agents / therapeutic use
-
Cultural Characteristics
-
Health Care Rationing* / economics
-
Health Care Rationing* / legislation & jurisprudence
-
Health Policy* / economics
-
Health Policy* / legislation & jurisprudence
-
Health Services Accessibility
-
Humans
-
Policy Making
-
Social Conditions